Burkitt lymphoma in adults: A prospective study of 72 patients treated with an adapted pediatric LMB protocol

Annals of Oncology

Volumn 16, Issue 12, 2005, Pages 1928-1935

  Divine M ^a   Casassus, P ^b   Koscielny, S ^c   Bosq, J ^c   Sebban, C ^d   Le Maignan, C ^e   Stamattoulas, A ^f   Dupriez, B ^g   Raphael M ^h   Pico, J L ^b   Ribrag, V ^c  

^a HENRI MONDOR HOSPITAL   (France)

^b AVICENNE HOSPITAL   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d CENTRE LÉON BÉRARD   (France)

^e HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^f CENTRE HENRI BECQUEREL   (France)

^g Hopital du Docteur Schaffner de Lens   (France)

^h BICÊTRE HOSPITAL   (France)

Author keywords

Adult patients; Burkitt lymphoma; Chemotherapy; Prognostic factors

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; FUROSEMIDE; HYDROCORTISONE; LACTATE DEHYDROGENASE; MELPHALAN; METHOTREXATE; PREDNISONE; STEROID; URATE OXIDASE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ADVANCED CANCER; AGED; ARTICLE; BLAST CELL; BONE MARROW SUPPRESSION; BONE MARROW TUMOR; BURKITT LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FATALITY; DRUG MEGADOSE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTICENTER STUDY; NEPHROTOXICITY; NEUROTOXICITY; PERIPHERAL NEUROPATHY; PHASE 2 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPSIS; SHOCK; SHORT COURSE THERAPY; SKIN INFECTION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR LYSIS SYNDROME; URINARY TRACT INFECTION;

EID: 28444455969     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdi403     Document Type: Article

References (23)

1. Bishop PC, Koneti Rao V, Wilson WH. Burkitt's lymphoma: Molecular pathogenesis and treatment. Cancer Invest 2000; 18: 574-583.
2. Diviné M, Lepage E, Brière J et al. Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. J Clin Oncol 1996; 14: 240-248.
3. Longo DL, Duffey PL, Jaffe ES et al. Diffuse small noncleaved-cell, non-Burkitt's lymphoma in adults: A high-grade lymphoma responsive to proMACE-based combination chemotherapy. J Clin Oncol 1994; 12: 2153-2159.
4. Jost LM, Jacky E, Dommann-Scherrer et al. Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patients. Ann Oncol 1995; 6: 445-451.
5. Strauss DJ, Wong GY, Liu J et al. Small non cleaved cell lymphoma (undifferentiated lymphoma, Burkitt's type) in American adults. Results with treatment designed for acute lymphoblastic leukemia. Am J Med 1991; 90: 328-337.
6. Larson RA, Dodge RK, Burns CP et al. A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B study 8811. Blood 1995; 85: 2025-2037.
7. Patte C, Philip T, Rodary C et al. Improved survival rate in children with stage III and IV B cell non- Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: Results of a study of 114 children from the French Pediatric Oncology Society. J Clin Oncol 1986; 4: 1219-1226.
8. Patte C, Philip T, Rodary C et al. High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: Results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol 1991; 9: 123-132.
9. Philip T, Hartmann O, Biron P et al. High-dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin's lymphoma. J Clin Oncol 1988; 6: 1118-1124.
10. Patte C, Auperin A, Michon J et al. The Socie'te Francxaise d'Oncologie Pediatrique LMB89 protocol: Highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood 2001; 97: 3370-3379.
11. Soussain C, Patte C, Ostronoff M et al. Small noncleaved cell lymphoma and leukemia in adults. A retrospective study of 65 adults treated with the LMB pediatric protocols. Blood 1995; 85: 664-674.
12. Hoelzer D, Ludwig W-D, Thiel E et al. Improved outcome in adult B-cell acute lymphoblastic leukemia. Blood 1996; 87: 495-508.
13. Thomas DA, Cortes J, O'Brien S et al. Hyper-CVAD program in Burkitt's type adult acute lymphoblastic leukemia. J Clin Oncol 1999; 17: 2461-2470.
14. Magrath I, Adde M, Shad A et al. Adults and children with small noncleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol 1996; 14: 925-934.
15. Lee AJ, Petroni G, Schiffer CA et al. Brief-duration high-intensity chemotherapy for patients with small-non cleaved lymphoma or FAB L3 acute lymphocytic leukemia: Results of Cancer and Leukemia Group B study 9251. J Clin Oncol 2001; 19: 4014-4022.
16. Mead GM, Sydes MR, Welewski J et al. An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study. Ann Oncol 2002; 13: 1264-1274.
17. Jaffe ES, Harris NL, Stein H, Vardiman JW. World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of Hematopoietic and Lymphoid Tissues. Lyon: IARC Press 2001; 181-184.
18. Murphy SB. Classification, staging and end results of treatment of childhood non- Hodgkin's lymphomas: Dissimilarities from lymphomas in adults. Semin Oncol 1980; 7: 332-339.
19. Sweetenham JW, Pearce R, Taghipour G et al. Adult Burkitt's and Burkitt-like non-Hodgkin's lymphoma. Outcome of patients treated with high-dose therapy and autologous stem-cell transplantation in first remission or at relapse: Results from the European Group for Blood and Marrow Transplantation. J Clin Oncol 1996; 14: 2465-2472.
20. Coiffier B, Lepage E, Briere J et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma. N Engl J Med 2002; 346: 235-242.
21. Veerman AJP, Nuijens JH, Van der Schoot CE, Kardos G, Zwaan Ch M. Rituximab in the treatment of childhood B-ALL and Burkitt's lymphoma, report on three cases. Blood 94; 1: 269b.
22. Cohen Y, Amir G, Rachmilewitz EA, Polliack A. Sustained complete remission following a combination of very low intensity chemotherapy with rituximab in an elderly patient with Burkitt's lymphoma. Haematologica 2002; 87: ELT 04.
23. Thomas DA, Cortes J, Giles FJ et al. Rituximab and Hyper-CVAD for adults Burkitts or Burkitt's like leukemia and lymphoma. Blood 2001; 16: 804a.